David Simmons

Western Sydney University, NSW, Australia

This delegate is presenting an abstract at this event.

Distinguished Professor Simmons is Professor of Medicine at Western Sydney University and Head of the Campbelltown Hospital Diabetes Service in Sydney. With over 480 refereed publications, he has won several national and international awards for his work in diabetes epidemiology, pregnancy and diabetes service development including the American Diabetes Association 2020 Norbert Freinkel Award and 2022 Diabetes in Pregnancy Study Group Pederson Awardee. He is the current president of the Australasian Diabetes in Pregnancy Society (ADIPS) and Chief Medical Officer for Diabetes Australia. He was the trial coordinator for the DALI lifestyle RCT to prevent GDM and is the Chief Investigator for the TOBOGM study the first large RCT of diagnosing and treating early gestational diabetes mellitus.

David Simmons

Western Sydney University, NSW, Australia

Reduction in pregnancy risk among young women with diabetes in a transition diabetes clinic (#63)

Investigating the role of the pharmacist in contraception and pre-pregnancy care for women with Type 1 and Type 2 diabetes in South West Sydney: patient and pharmacist perspectives (#47)

Insulin isophane allergy in gestational diabetes mellitus. (#65)

An early pregnancy HbA1c ≥5.9% (41 mmol/mol) is not a valid biomarker for early or late gestational diabetes mellitus and does not predict adverse pregnancy outcomes in obese pregnant women (#72)

The metabolic phenotypes of early onset gestational diabetes mellitus (GDM) and their association with adverse pregnancy outcomes (#13)

Relationship between sleep and snoring and body mass index among women with risk factors for gestational diabetes mellitus at booking: Preliminary findings from a multicentre randomized trial (#73)

Evaluation of the Diabetes Contraception and Pre-pregnancy Program (DCAPP) in General Practice. (#74)

Impact of changes in diagnostic criteria for gestational diabetes on maternal characteristics and pregnancy outcomes (#79)

Perceptions of risk and experiences of gestational diabetes mellitus among Australian Samoan women in South Western Sydney. (#59)

Associations of late third trimester HbA1c with adverse pregnancy outcomes in women with gestational diabetes. (#66)

Implementation of an integrated, district-wide Diabetes Contraception and Pre-pregnancy Program (DCAPP) among women with Type 1 and 2 diabetes: an update (#77)

ADIPS Diabetes in Pregnancy Clinical Audit Programme (#11)

Perspectives on GDM (#24)

Contact David Simmons

Login

An early pregnancy HbA_1c ≥5.9% (41 mmol/mol) is not a valid biomarker for early or late gestational diabetes mellitus and does not predict adverse pregnancy outcomes in obese pregnant women (#72)